approved glp 1 agonists List of and pending GLP-1 medications A clinician's perspective π GLP-1
Description
Trulicity may be taken with or without food
Abstract Purpose of Review The purpose of this review is two-fold: (1) to discuss a case report of idiopathic intracranial hypertension (IIH) after abrupt cessation of a glucagon-like peptide-1 (GLP-1) receptor agonist with resultant rapid weight gain and (2) to review the literature regarding the potential role of GLP-1 receptor agonists in the treatment of IIH as well as potential pitfalls

What does the history of GLP-1 medications in the US look like
That study will provide insights into the potential of GLP-1 RAs to modify the disease course in HFpEF patients

T.GeerlingJ

Ussher, J
